In ₹ Crore except Per Share Latest Annual	GUFICBIO FY26	RPGLIFE FY26	UNICHEMLAB FY26	GUJTHEM FY26	Peer Average
Valuation — at last close
P/E	66.21×	157.30×	◆ 13.61×	83.07×	84.66× -22%
P/B	6.39×	7.77×	◆ 1.27×	13.46×	7.50× -15%
EV/EBITDA	30.12×	30.24×	◆ 19.63×	53.33×	34.40× -12%
Market Cap	₹4,249 Cr	₹4,703 Cr	₹3,441 Cr	₹3,874 Cr	₹4,006 Cr +6%
Growth
Revenue CAGR 3Y	—	—	17.91%	—	17.91%
Revenue CAGR 5Y	—	—	12.26%	—	12.26%
Revenue YoY (latest Q)	16.58%	—	20.13%	◆ 22.07%	21.10% -21%
Net Income YoY (latest Q)	70.71%	—	◆ 496.08%	22.12%	259.10% -73%
Profitability
EBITDA Margin	16.03%	20.79%	8.36%	◆ 45.55%	24.90% -36%
Net Income Margin	6.80%	16.28%	11.48%	◆ 28.15%	18.64% -64%
Return on Common Equity	10.14%	◆ 20.28%	9.78%	17.41%	15.82% -36%
Return on Capital Employed	15.00%	◆ 21.46%	2.18%	17.76%	13.80% +9%
Return on Assets	5.11%	◆ 15.88%	6.92%	11.60%	11.47% -55%
Credit & Quality
Total Debt/Equity	0.58×	◆ 0.03×	0.17×	0.56×	0.25× +129%
Interest Coverage	3.29×	◆ 141.13×	1.87×	21.23×	54.74× -94%
Scale — latest FY
Revenue / Total Income	₹944 Cr	₹708 Cr	₹2,202 Cr	₹166 Cr	₹1,025 Cr -8%
Net Income	₹64.2 Cr	₹115 Cr	₹253 Cr	₹46.7 Cr	₹138 Cr -54%
Total Assets	₹1,342 Cr	₹793 Cr	₹3,737 Cr	₹503 Cr	₹1,678 Cr -20%
EPS	₹6.4	₹18.08	₹35.91	₹4.28	₹19.42 -67%
Book Value per Share	₹66.31	₹366.07	₹386	₹26.41	₹259.49 -74%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.